Big tech earnings, fiscal stimulus, vaccines conspired to rally stocks. Tech and SMIDs drove the gains. Stocks + Treasuries + US dollar + commodities +
The market made a rapid reversal that has weakened the short-term upward trend in the indexes. The significance of GME while entertaining is still conjectural.
US equities hit new highs on most of the indexes. Upward momentum is waning and the internal market dynamics are corrective in nature. Biotechnology firms
As National Coordinator for Health IT, the interoperability veteran will bring deep standards expertise as the rubber hits the road on nationwide API-based data exchange.
As
The US equities are trying to deal with so much liquidity and an extreme bullish sentiment that we are just sloshing and whooshing. Good for
Now what? With 2020 in the rearview mirror we break down the forces that will shape the trajectory of digital health over the next twelve
Last week for stocks was more or less a continuation of what had happened from November onward. One hopes with resolution of some things we
Activity is slowing down and continuation patterns proliferate. NDX is more bullish than SPX. SPX sectors are sideways to mild correction except XLK, XLY +/-
There has been an explosion of digital health innovation in clinical trials. The Rock Health Consulting team explores this evolution and what the next horizon
Momentum declined last week and with net bullish sentiment is not a great setup for further gains short term. The indexes are overbought but not
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.
